ArticleJournal of thrombosis and thrombolysis2022

Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapy.

Jingshi Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.